Announcements
14 July 2023
Meet Us at 2023 BMES Annual Meeting, 11–14 October 2023, Seattle, USA
11 July 2023
Cancers | Highly Cited Papers and Hot Topic Special Issues on Methods and Technologies Development
We are delighted to share some highly cited papers on methods and technologies development that were published in the journal Cancers (ISSN: 2072-6694) in 2021 and 2022. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues which we believe will be of interest to you.
“Artificial Intelligence for Thyroid Nodule Characterization: Where Are We Standing?”
by Salvatore Sorrenti, Vincenzo Dolcetti, Maija Radzina, Maria Irene Bellini, Fabrizio Frezza, Khushboo Munir, Giorgio Grani, Cosimo Durante, Vito D’Andrea, Emanuele David et al.
Cancers 2022, 14(14), 3357; https://doi.org/10.3390/cancers14143357
Available online: https://www.mdpi.com/2072-6694/14/14/3357
“A Review of Circulating Tumour Cell Enrichment Technologies”
by Amelia J. Rushton, Georgios Nteliopoulos, Jacqueline A. Shaw and R. Charles Coombes
Cancers 2021, 13(5), 970; https://doi.org/10.3390/cancers13050970
Available online: https://www.mdpi.com/2072-6694/13/5/970
“Novel Transfer Learning Approach for Medical Imaging with Limited Labeled Data”
by Laith Alzubaidi, Muthana Al-Amidie, Ahmed Al-Asadi, Amjad J. Humaidi, Omran Al-Shamma, Mohammed A. Fadhel, Jinglan Zhang, J. Santamaría and Ye Duan
Cancers 2021, 13(7), 1590; https://doi.org/10.3390/cancers13071590
Available online: https://www.mdpi.com/2072-6694/13/7/1590
“Organoid and Spheroid Tumor Models: Techniques and Applications”
by Sreenivasulu Gunti, Austin T. K. Hoke, Kenny P. Vu and Nyall R. London, Jr.
Cancers 2021, 13(4), 874; https://doi.org/10.3390/cancers13040874
Available online: https://www.mdpi.com/2072-6694/13/4/874
“Stimuli-Responsive Hydrogels for Cancer Treatment: The Role of pH, Light, Ionic Strength and Magnetic Field”
by Fernanda Andrade, Maria Mercé Roca-Melendres, Esteban F. Durán-Lara, Diana Rafael and Simó Schwartz, Jr.
Cancers 2021, 13(5), 1164; https://doi.org/10.3390/cancers13051164
Available online: https://www.mdpi.com/2072-6694/13/5/1164
“Recent Advances in Zinc Oxide Nanoparticles (ZnO NPs) for Cancer Diagnosis, Target Drug Delivery, and Treatment”
by Sumaira Anjum, Mariam Hashim, Sara Asad Malik, Maha Khan, José M. Lorenzo, Bilal Haider Abbasi and Christophe Hano
Cancers 2021, 13(18), 4570; https://doi.org/10.3390/cancers13184570
Available online: https://www.mdpi.com/2072-6694/13/18/4570
|
“Recent Trends in PET/CT Tracer Development and Multimodal Imaging” Edited by: Prof. Dr. Olaf Prante and Prof. Dr. Tobias Bäuerle
|
“New Technologies in Brain Tumor Diagnosis and Therapies: Basic, Clinical, and Translational Research” Edited by: Dr. Mingli Liu |
|
“Application of Advanced Biomedical Imaging in Cancer Treatment” Edited by: Prof. Dr. Edyta Szurowska and Dr. Maciej Bobowicz
|
“Artificial Intelligence and Machine Learning in Precision Oncology” Edited by: Dr. Carmen Belli and Dr. Santosh Anand
|
We hope this announcement will provide useful information for this field.
11 July 2023
MDPI’s Newly Launched Journals in June 2023
With the first issue released in June 2023, five new MDPI journals disseminating multi-disciplinary science are due to launch, which will cover the subjects of medicine & pharmacology, biology and physical sciences.
The newly launched journals will be overseen by professional Editorial Board Members and Editors to ensure an accurate and rapid publication, rigorous peer review and broad visibility.
Please feel free to browse and discover more about the new journals below.
| Journal | Founding Editor-in-Chief | Journal topics (selected) |
 |
Prof. Dr. Jun Ma, Peking University, China| Editorial | view inaugural issue | growth and development; diet and nutrients; school health promotion policies and practices; child health and care; adolescent health and wellbeing | view journal scope | submit an article |
 |
Prof. Dr. Bernd Rehm, Griffith University, Australia | Editorial | view inaugural issue | DNA and gene synthesis; synthetic transcription factors; protein engineering; viral engineering; metabolic engineering | view journal scope | submit an article |
 |
Prof. Dr. Varsha Gandhi, University of Texas MD Anderson Cancer Center, USA | Editorial | view inaugural issue | lymphatics; cancers associated with lymphocytes and lymphoblasts; lymphatic tissues; lymphoma; lymphoid leukemia | view journal scope | submit an article |
 |
Dr. Bradley Turner, University of Melbourne, Australia | Editorial | view inaugural issue | multiple sclerosis; amyotrophic lateral sclerosis; primary lateral sclerosis; atherosclerosis; systemic sclerosis | view journal scope | submit an article |
 |
Prof. Dr. Clemens Burda, Case Western Reserve University, USA | Editorial | view inaugural issue | Gamma ray, X-ray, and UV–Vis spectroscopies; NIR/mid-infrared/Raman spectroscopy; microwave and THz spectroscopy; high-resolution gas-phase atomic, molecular, and cluster spectroscopy; MS, NMR, and EPR spectroscopy | view journal scope | submit an article |
We wish to thank everyone who has supported the development of open access publishing. You are welcome to submit an application to the New Journal Committee (newjournal-committee@mdpi.com) if you would like to create more new journals.
7 July 2023
Cancers | Highly Cited Papers and Hot Topic Special Issues
We are delighted to share some highly cited papers that were published in the journal Cancers (ISSN: 2072-6694) in 2021 and 2022. In addition, some Special Issues are open for submission. The following is a list of articles and Special Issues which we believe will be of interest to you.
“Oral–Gut Microbiome Axis in Gastrointestinal Disease and Cancer”
by Se-Young Park, Byeong-Oh Hwang, Mihwa Lim, Seung-Ho Ok, Sun-Kyoung Lee, Kyung-Soo Chun, Kwang-Kyun Park, Yinling Hu, Won-Yoon Chung and Na-Young Song
Cancers 2021, 13(9), 2124; https://doi.org/10.3390/cancers13092124
Available online: https://www.mdpi.com/2072-6694/13/9/2124
“Determination of Exosome Mitochondrial DNA as a Biomarker of Renal Cancer Aggressiveness”
by Elena Arance, Viviana Ramírez, Alejandro Rubio-Roldan, Francisco M. Ocaña-Peinado, Catalina Romero-Cachinero, Ana Belén Jódar-Reyes, Fernando Vazquez-Alonso, Luis Javier Martinez-Gonzalez and Maria Jesus Alvarez-Cubero
Cancers 2022, 14(1), 199; https://www.mdpi.com/2072-6694/14/1/199
Available online: https://www.mdpi.com/2072-6694/14/1/199
“Classification of Breast Cancer Nottingham Prognostic Index Using High-Dimensional Embedding and Residual Neural Network”
by Li Zhou, Maria Rueda and Abedalrhman Alkhateeb
Cancers 2022, 14(4), 934; https://doi.org/10.3390/cancers14040934
Available online: https://www.mdpi.com/2072-6694/14/4/934
“The Evolution of Ovarian Carcinoma Subclassification”
by Martin Köbel and Eun Young Kang
Cancers 2022, 14(2), 416; https://doi.org/10.3390/cancers14020416
Available online: https://www.mdpi.com/2072-6694/14/2/416
“The Role of Dielectrophoresis for Cancer Diagnosis and Prognosis”
by Giorgio Ivan Russo, Nicolò Musso, Alessandra Romano, Giuseppe Caruso, Salvatore Petralia, Luca Lanzanò, Giuseppe Broggi and Massimo Camarda
Cancers 2022, 14(1), 198; https://doi.org/10.3390/cancers14010198
Available online: https://www.mdpi.com/2072-6694/14/1/198
“Impact of the COVID-19 Pandemic on Cancer Diagnoses in General and Specialized Practices in Germany”
by Louis Jacob, Sven H. Loosen, Matthias Kalder, Tom Luedde, Christoph Roderburg and Karel Kostev
Cancers 2021, 13(3), 408; https://doi.org/10.3390/cancers13030408
Available online: https://www.mdpi.com/2072-6694/13/3/408
“Chemotherapy Side-Effects: Not All DNA Damage Is Equal”
by Winnie M. C. van den Boogaard, Daphne S. J. Komninos and Wilbert P. Vermeij
Cancers 2022, 14(3), 627; https://doi.org/10.3390/cancers14030627
Available online: https://www.mdpi.com/2072-6694/14/3/627
“Timely Palliative Care: Personalizing the Process of Referral”
by David Hui, Yvonne Heung and Eduardo Bruera
Cancers 2022, 14(4), 1047; https://doi.org/10.3390/cancers14041047
Available online: https://www.mdpi.com/2072-6694/14/4/1047
|
“Advances in Ovarian Cancer Research and Treatment” Edited by: Dr. Maria Barbolina
|
“Advances in Brachytherapy in the Treatment of Tumors” Edited by: Dr. Hideya Yamazaki |
|
“Molecular Biology of Colorectal Cancers” Edited by: Dr. María Jesús Fernández-Aceñero, Dr. Rodrigo Barderas-Manchado, Dr. Javier Martinez Useros and Dr. Cristina Díaz del Arco
|
“Palliative Care in Cancer: Recent Advances and Upcoming Trends” Edited by: Prof. Dr. Philipp Lenz and Dr. Mitra Tewes
|
We hope this announcement will provide useful information for this field.
5 July 2023
Cancers | Highly Cited Papers and Hot Topic Special Issues on Breast Cancer Research
We are delighted to share some highly cited papers on breast cancer research that were published in the journal Cancers (ISSN: 2072-6694) in 2021 and 2022. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues that we believe will be of interest to you.
“Breast Tumour Classification Using Ultrasound Elastography with Machine Learning: A Systematic Scoping Review”
by Ye-Jiao Mao, Hyo-Jung Lim, Ming Ni, Wai-Hin Yan, Duo Wai-Chi Wong and James Chung-Wai Cheung
Cancers 2022, 14(2), 367; https://doi.org/10.3390/cancers14020367
Available online: https://www.mdpi.com/2072-6694/14/2/367
“Exosomes as Emerging Drug Delivery and Diagnostic Modality for Breast Cancer: Recent Advances in Isolation and Application”
by Dulla Naveen Kumar, Aiswarya Chaudhuri, Farrukh Aqil, Deepa Dehari, Radha Munagala, Sanjay Singh, Ramesh C. Gupta and Ashish Kumar Agrawal
Cancers 2022, 14(6), 1435; https://doi.org/10.3390/cancers14061435
Available online: https://www.mdpi.com/2072-6694/14/6/1435
“Role of ctDNA in Breast Cancer”
by Marta Sant, Adrià Bernat-Peguera, Eudald Felip and Mireia Margelí
Cancers 2022, 14(2), 310; https://doi.org/10.3390/cancers14020310
Available online: https://www.mdpi.com/2072-6694/14/2/310
“Triple Negative Breast Cancer: Updates on Classification and Treatment in 2021”
by Maroun Bou Zerdan, Tala Ghorayeb, Fares Saliba, Sabine Allam, Morgan Bou Zerdan, Marita Yaghi, Nadeem Bilani, Rola Jaafar and Zeina Nahleh
Cancers 2022, 14(5), 1253; https://doi.org/10.3390/cancers14051253
Available online: https://www.mdpi.com/2072-6694/14/5/1253
“HER2-Low Breast Cancer: Molecular Characteristics and Prognosis”
by Elisa Agostinetto, Mattia Rediti, Danai Fimereli, Véronique Debien, Martine Piccart, Philippe Aftimos, Christos Sotiriou and Evandro de Azambuja
Cancers 2021, 13(11), 2824; https://doi.org/10.3390/cancers13112824
Available online: https://www.mdpi.com/2072-6694/13/11/2824
“Molecular Targets of Triple-Negative Breast Cancer: Where Do We Stand?”
by Emma E. Newton, Lauren E. Mueller, Scout M. Treadwell, Cindy A. Morris and Heather L. Machado
Cancers 2022, 14(3), 482; https://doi.org/10.3390/cancers14030482
Available online: https://www.mdpi.com/2072-6694/14/3/482
|
“Comprehensive Genomic Profiling for Metastatic Breast Cancer: Current Status and Future Perspectives” Edited by: Dr. Hiroshi Tada and Dr. Hiroko Masuda
|
“Single Cell RNA Sequencing in Breast Cancer” Edited by: Dr. Yu-Chih Chen |
|
“Molecular Mechanisms in Breast Cancer Therapy and Resistance” Edited by: Dr. Lei Duan
|
“BRCA-Associated Breast Cancer” Edited by: Dr. Matilde Pensabene, Dr. Carmine De Angelis and Prof. Dr. Matteo Lambertini
|
We hope this announcement will provide useful information for this field.
4 July 2023
Cancers | Highly Cited Papers and Hot Topic Special Issues on Cancer Resistance Research
We are delighted to share some highly cited papers on cancer resistance research that were published in the journal Cancers (ISSN: 2072-6694) in 2021 and 2022. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues which we believe will be of interest to you. The list of relevant papers can be seen below:
“Mechanisms of Resistance to KRASG12C Inhibitors”
by Victoria Dunnett-Kane, Pantelis Nicola, Fiona Blackhall and Colin Lindsay
Cancers 2021, 13(1), 151; https://doi.org/10.3390/cancers13010151
Available online: https://www.mdpi.com/2072-6694/13/1/151
“Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance”
by Christiana M. Neophytou, Ioannis P. Trougakos, Nuray Erin and Panagiotis Papageorgis
Cancers 2021, 13(17), 4363; https://doi.org/10.3390/cancers13174363
Available online: https://www.mdpi.com/2072-6694/13/17/4363
“Mechanisms of Resistance to Conventional Therapies for Osteosarcoma”
by Louise Marchandet, Morgane Lallier, Céline Charrier, Marc Baud’huin, Benjamin Ory and François Lamoureux
Cancers 2021, 13(4), 683; https://doi.org/10.3390/cancers13040683
Available online: https://www.mdpi.com/2072-6694/13/4/683
“Immune Resistance in Lung Adenocarcinoma”
by Magda Spella and Georgios T. Stathopoulos
Cancers 2021, 13(3), 384; https://doi.org/10.3390/cancers13030384
Available online: https://www.mdpi.com/2072-6694/13/3/384
“Recent Insights into Therapy Resistance in Osteosarcoma”
by Zachary D. Prudowsky and Jason T. Yustein
Cancers 2021, 13(1), 83; https://doi.org/10.3390/cancers13010083
Available online: https://www.mdpi.com/2072-6694/13/1/83
“EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance”
by Mary Luz Uribe, Ilaria Marrocco and Yosef Yarden
Cancers 2021, 13(11), 2748; https://doi.org/10.3390/cancers13112748
Available online: https://www.mdpi.com/2072-6694/13/11/2748
Special Issues:
|
“The Role of Epithelial-Mesenchymal Transition in Therapies Resistance and Cancer Metastasis” Edited by: Dr. Pierre Savagner
|
“State-of-the-Art Mechanisms of Drug Resistance to Targeted Therapy in Cancers” Edited by: Dr. Yan Li |
|
“Drug Resistance in Gastrointestinal Cancer” Edited by: Dr. Rosalba D’Alessandro and Dr. Carmelo Ferrai
|
“Triple Negative Breast Cancer Therapy Resistance and Metastasis” Edited by: Dr. Daniela Sousa
|
4 July 2023
Cancers Receives an Updated Impact Factor of 5.2
3 July 2023
MDPI Insights: The CEO's Letter #1 - Open Access and Impactful Research
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
The Future is Open, and MDPI is Leading the Way
I strongly believe in a future that embraces openness, where open source, open information, and open access (OA) take center stage. This belief that led me to join MDPI in 2020, and I am honored to have recently been appointed as Chief Executive Officer (CEO). In this capacity, and operating in close liaison with Dr. Lin and MDPI’s senior management, I shall work to build on Dr. Lin’s achievements of the past quarter-century. In this role, I will focus on communication initiatives to promote MDPI's remarkable work and continue to build our company as a trusted leader in OA publishing. For over two decades, MDPI has been at the forefront of reshaping the academic publishing landscape, with OA surpassing subscription-based publishing in 2020. This trajectory is deeply rooted in our history and reflects our unwavering commitment and vision for an open future.
1 Million Published Articles
2023 began with a remarkable achievement for MDPI, as we became the first OA publisher to reach the milestone of 1 million published articles. This represents 2.7 million unique authors who have trusted us with their work, or about a third of all researchers worldwide. As the world's most cited OA publisher, we are proud in sharing these significant milestones.
Our mission remains unchanged: to make science open and accessible to all. We understand the importance of knowledge access, empowering researchers to stay at the forefront of a rapidly changing world. Our diverse range of journals covers a wide spectrum of disciplines, offering cutting-edge insights, trusted tools, and crucial knowledge to address global challenges.
Liberating Science
As the world’s leading OA publisher, MDPI is actively liberating science. We are committed to eliminating the frustrations researchers and the general public face when accessing information, ensuring it is not locked behind paywalls. We firmly believe that everyone has a right to information, and our commitment to open access publishing drives our work.
In this inaugural edition of Insights: The CEO's Letter, I draw inspiration from the upcoming 20th anniversary of the Berlin Declaration on Open Access. Its stated mission reminds us that true impact is achieved when knowledge is widely and readily available to society:
"Our mission of disseminating knowledge is only half complete if the information is not made widely and readily available to society”
Impactful Research
MDPI Publishes Impactful Research: Recognized by Leading Indexing Databases
MDPI journals are indexed in every single top database in the world.
As of June 2023, we have 214 journals indexed within Web of Science, 223 indexed within Scopus, 87 indexed within PubMed and PMC, and 17 indexed within MEDLINE, and these numbers increase every month. We constantly strive to expand the coverage of our journals within leading multi-disciplinary and scope-specific databases, resulting in an incredibly broad range of journals that are indexed within a variety of databases. MDPI has active relationships with approximately 65 well-known databases around the world, and we continue to expand our portfolio every year so that your work can be found, cited, and referenced with ease.
Continued Growth of MDPI Journals
The 2022 Scopus and Web of Science journal citation metrics were officially released in June, and I am pleased to report that 31 MDPI journals received their first CiteScore, taking the total number of journals with a CiteScore to 216. The number of MDPI journals receiving an Impact Factor (IF) also continues to grow with 111 receiving their first, by being covered in the ESCI, bringing our total number of journals with an IF to 208 of which 41 journals received an IF above 4.0. Looking at 2022 CiteScores in the Scopus database, 80% of MDPI journals have a score that ranks them in Q1 or Q2 in at least one subject category.
Publishing impactful science would not be possible without all of our authors, editors and reviewers. Thank you for your contribution and continued support! Together we share the latest scientific insights faster and ensure that your work is accessible to all.
Read more
Inside MDPI
Preprints.org: Clarivate adds the Preprint Citation Index to the Web of Science
At MDPI, we are dedicated to driving the advancement of science. Through our initiative, Preprints.org, researchers can publish their work and gain valuable feedback from the broader research community, ensuring rapid progress in their respective fields. This is particularly crucial during times of health and climate challenges, where timely dissemination of findings is essential.
Increased Visibility for Preprints
I am pleased to share that Clarivate recognizes the significance of preprints and has taken a crucial step to enhance their visibility. Clarivate has added the Preprint Citation Index to the Web of Science, encompassing preprints published not only on Preprints.org but also on other reputable repositories.
Looking ahead, the future of preprints appears promising, bolstered by the recent indexing announcement from the Web of Science. As a result, preprints will receive increased visibility, serving as a valuable resource for staying informed about the latest research developments.
Read more
What are Preprints?
The Pros and Cons of Preprints
Preprints and COVID-19
Preprints—The Future of Open Access Publishing?
Coming Together for Science
The First International Conference on Antioxidants: Sources, Methods, Health Benefits and Industrial Applications
In this edition of ‘Coming Together for Science,’ I am pleased to highlight the First International Conference on Antioxidants organized by our conference team in the beautiful city of Barcelona, Spain. The conference attracted over 130 attendees, who engaged in 42 talks, and 89 poster presentations spread across several sessions.
Working Together
Under the leadership of Prof. Dr. Alessandra Napolitano (Department of Chemical Sciences, University of Naples ‘Federico II’, Naples, Italy) and Prof. Dr. Rosa M. Lamuela Raventos (Department of Nutrition, Food Sciences and Gastronomy, University of Barcelona, Spain) as chairs, and supported by the committee members, 10 invited keynote speakers, poster presenters, and all the attendees, this dedicated group of academics came together to discuss the natural sources, methodologies, health benefits, and industrial applications of antioxidants.
Especially noteworthy is the positive feedback received from attendees, with 94% rating the overall organization of the conference as good or excellent. I particularly love the picture above, capturing the gathering of some of the participants. You can browse through more photos in the event gallery located here.
Managing Events With Sciforum
If you are considering hosting your own academic event, I highly recommend checking out Sciforum, MDPI's event management platform. Sciforum simplifies the entire process, making it easy to host your own event by allowing you to focus on what really matters: Science!
Read more
Closing Thoughts
Stefan Tochev, Dr. Shu-Kun Lin, Dr. Eric O. Freed, Peter Roth, Wynne Wang, Allison Yang
Viruses and Editorial Quality: Acknowledging the Dedication of our Viruses Journal Team
During a June meeting with Dr. Eric O. Freed, the founding and current Editor-in-Chief of our journal Viruses, I was reminded of the exceptional dedication of our editorial board. Meeting with Eric is a pleasure, as he has a strong commitment and clear vision for the journal. Over the course of two days, we gained a deep understanding of the journal’s expectations and focus on strategic growth, editorial board representation, and engagement.
I am pleased to share that Viruses holds a CiteScore of 7.1 (an increase of 7.57% versus the 2021 metric) and an Impact Factor of 4.7. You can view the journal statistics here. Viruses publishes highly cited papers, and is indexed in renowned databases such as Scopus, SCIE (Web of Science), PubMed, and others, and maintains affiliations with prestigious societies. Moreover, the Viruses team has recently announced an exciting upcoming event titled ‘Viruses 2024 – A World of Viruses,’ scheduled to take place in Barcelona, Spain, from 14–16 February 2024.
Testimonials
If you notice my enthusiasm regarding our editorial service, it’s because the surveys and testimonials we receive speak volumes about the experiences of our authors, reviewers, and guest editors who collaborate with MDPI. The purpose of these letters is to highlight the exceptional work that we do and the experiences we create for the scholars – thus, let me end with this testimonial from an author:
“It was a great pleasure to publish in Viruses Special Issue [Emerging Viruses in Aquaculture]. The submission process was easy. Guest editors were very helpful and provided all the guidance and support as needed. The handling of the manuscript by the Editorial Team was very fast, efficient, and professional. The reviewer’s comments were insightful, and the publication processes were remarkably rapid.”
– Ms. Magdalena Stachnik, Państwowy Instytut Weterynaryjny | PIWet
Article in Viruses: Emerging Viral Pathogens in Sturgeon Aquaculture in Poland: Focus on Herpesviruses and Mimivirus Detection
Chief Executive Officer
MDPI AG
29 June 2023
Cancers | Highly Cited Papers and Hot Topic Special Issues on Cancer Epidemiology and Prevention
We are delighted to share some highly cited papers on cancer epidemiology and prevention that were published in the journal Cancers (ISSN: 2072-6694) in 2021 and 2022. In addition, some Special Issues on this topic are open for submission.
“Colorectal Cancer: A Review of Carcinogenesis, Global Epidemiology, Current Challenges, Risk Factors, Preventive and Treatment Strategies”
by Md. Sanower Hossain, Hidayah Karuniawati, Ammar Abdulrahman Jairoun, Zannat Urbi, Der Jiun Ooi, Akbar John, Ya Chee Lim, K. M. Kaderi Kibria, A. K. M. Mohiuddin, Long Chiau Ming et al.
Cancers 2022, 14(7), 1732; https://doi.org/10.3390/cancers14071732
Available online: https://www.mdpi.com/2072-6694/14/7/1732
“A Review of Colorectal Cancer in Terms of Epidemiology, Risk Factors, Development, Symptoms and Diagnosis”
by Tomasz Sawicki, Monika Ruszkowska, Anna Danielewicz, Ewa Niedźwiedzka, Tomasz Arłukowicz and Katarzyna E. Przybyłowicz
Cancers 2021, 13(9), 2025; https://doi.org/10.3390/cancers13092025
Available online: https://www.mdpi.com/2072-6694/13/9/2025
“Epidemiology of Glioblastoma Multiforme–Literature Review”
by Szymon Grochans, Anna Maria Cybulska, Donata Simińska, Jan Korbecki, Klaudyna Kojder, Dariusz Chlubek and Irena Baranowska-Bosiacka
Cancers 2022, 14(10), 2412; https://doi.org/10.3390/cancers14102412
Available online: https://www.mdpi.com/2072-6694/14/10/2412
“Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated Review”
by Sergiusz Łukasiewicz, Marcin Czeczelewski, Alicja Forma, Jacek Baj, Robert Sitarz and Andrzej Stanisławek
Cancers 2021, 13(17), 4287; https://doi.org/10.3390/cancers13174287
Available online: https://www.mdpi.com/2072-6694/13/17/4287
“Global Burden, Risk Factors, and Trends of Esophageal Cancer: An Analysis of Cancer Registries from 48 Countries”
by Junjie Huang, Anastasios Koulaouzidis, Wojciech Marlicz, Veeleah Lok, Cedric Chu, Chun Ho Ngai, Lin Zhang, Ping Chen, Shanjuan Wang, Jinqiu Yuan et al.
Cancers 2021, 13(1), 141; https://doi.org/10.3390/cancers13010141
Available online: https://www.mdpi.com/2072-6694/13/1/141
|
“Feature Paper in Section “Cancer Epidemiology and Prevention” in 2022–2023“ |
“How COVID-19 Affects Cancer Patients“ |
|
“Colorectal Cancer: Epidemiology and Prevention“ |
“Inherited Breast Cancer Risk: BRCA Mutations and Beyond“ |
We hope this announcement will provide useful information for this field.
29 June 2023
Cancers | Highly Cited Papers and Hot Topic Special Issues on Cancer Therapy
We are delighted to share some highly cited papers on cancer therapy research that were published in the journal Cancers (ISSN: 2072-6694) in 2021 and 2022. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues which we believe will be of interest to you.
"STING Agonists as Cancer Therapeutics"
by Afsaneh Amouzegar, Manoj Chelvanambi, Jessica N. Filderman, Walter J. Storkus and Jason J. Luke
Cancers 2021, 13(11), 2695; https://doi.org/10.3390/cancers13112695
Available online: https://www.mdpi.com/2072-6694/13/11/2695
"MMP9: A Tough Target for Targeted Therapy for Cancer"
by Katarzyna Augoff, Anita Hryniewicz-Jankowska, Renata Tabola and Kamilla Stach
Cancers 2022, 14(7), 1847; https://doi.org/10.3390/cancers14071847
Available online: https://www.mdpi.com/2072-6694/14/7/1847
"Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives"
by Nora Berois, Alvaro Pittini and Eduardo Osinaga
Cancers 2022, 14(3), 645; https://doi.org/10.3390/cancers14030645
Available online: https://www.mdpi.com/2072-6694/14/3/645
"The KEAP1–NRF2 System as a Molecular Target of Cancer Treatment"
by Keiko Taguchi and Masayuki Yamamoto
Cancers 2021, 13(1), 46; https://doi.org/10.3390/cancers13010046
Available online: https://www.mdpi.com/2072-6694/13/1/46
"Photodynamic Therapy: A Compendium of Latest Reviews"
by José Francisco Algorri, Mario Ochoa, Pablo Roldán-Varona, Luís Rodríguez-Cobo and José Miguel López-Higuera
Cancers 2021, 13(17), 4447; https://doi.org/10.3390/cancers13174447
Available online: https://www.mdpi.com/2072-6694/13/17/4447
"Recurrent Glioblastoma: From Molecular Landscape to New Treatment Perspectives"
by Cristina Birzu, Pim French, Mario Caccese, Giulia Cerretti, Ahmed Idbaih, Vittorina Zagonel and Giuseppe Lombardi
Cancers 2021, 13(1), 47; https://doi.org/10.3390/cancers13010047
Available online: https://www.mdpi.com/2072-6694/13/1/47
"Targeting BCL-2 in Cancer: Advances, Challenges, and Perspectives"
by Shirin Hafezi and Mohamed Rahmani
Cancers 2021, 13(6), 1292; https://doi.org/10.3390/cancers13061292
Available online: https://www.mdpi.com/2072-6694/13/6/1292
|
“Feature Review for Cancer Therapy”
|
“Novel Therapeutic Strategies in Salivary Gland Tumor” |
|
“State-of-the-Art Mechanisms of Drug Resistance to Targeted Therapy in Cancers” |
“New Strategies in Diagnosis and Treatments for Brain Tumors (Volume II)” |
We hope this announcement will provide useful information for this field.
